Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease

CONCLUSION: While their efficacy needs to be better evaluated through large-scale, multicenter, randomized clinical trials, these novel agents show potential and could provide a better alternative for SR-GVHD treatment in the future.PMID:38094101 | PMC:PMC10718798 | DOI:10.1155/2023/9949961

Source: Advances in Hematology - December 14, 2023 Category: Hematology Authors: Iuliia Kovalenko Tabinda Saleem Mitali Shah Sara Seyedroudbari Konstantin Golubykh Rimsha Ali Taaha Mirza Babray Laek Ahsan Wahab Asmi Chattaraj Ekaterina Proskuriakova Chandi Garg Rafiullah Khan Source Type: research